SCHEMBL22409640

SCHEMBL22409640

O=C1NC(=O)C(=CC=Cc2ccnc3ccccc23)S1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CISD1 Q9NZ45 4/20 0.49
▸ PIK3CD O00329 2/20 0.46
▸ CSNK2A2 P19784 2/20 0.46
▸ PIK3CA P42336 2/20 0.46
▸ PIK3CB P42338 2/20 0.46
▸ MTOR P42345 2/20 0.46
▸ PIK3CG P48736 2/20 0.46
▸ CLK1 P49759 2/20 0.46
▸ DYRK1A Q13627 2/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ MAOB P27338 1/20 0.46
▸ CSNK2B P67870 1/20 0.46
▸ CSNK2A1 P68400 1/20 0.46
▸ DYRK2 Q92630 1/20 0.46
▸ DYRK1B Q9Y463 1/20 0.46
▸ PIM1 P11309 2/20 0.46
▸ GAK O14976 1/20 0.46
▸ RPS6KA4 O75676 1/20 0.46
▸ STK10 O94804 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22423741 1.00 CISD1 (0.49) CISD1PIK3CDCSNK2A2PIK3CAPIK3CB
SCHEMBL1250371 0.84 CISD1 (0.64) CISD1PIK3CDCSNK2A2PIK3CAPIK3CB
SCHEMBL1250373 0.84 CISD1 (0.64) CISD1PIK3CDCSNK2A2PIK3CAPIK3CB
SCHEMBL22423783 0.78 METAP1 (0.52) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL22409618 0.78 METAP1 (0.52) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL8188174 0.76 MTOR (0.50) CISD1PIK3CDCSNK2A2PIK3CAPIK3CB
SCHEMBL13846678 0.72 PIM1 (0.67) RAB9APIM1ALDH1A1MEN1KMT2A
SCHEMBL22409611 0.72 PIM1 (0.67) RAB9APIM1ALDH1A1MEN1KMT2A
SCHEMBL22423780 0.72 PIM1 (0.67) RAB9APIM1ALDH1A1MEN1KMT2A
SCHEMBL8310559 0.72 PIM1 (0.64) CISD1PIK3CDCSNK2A2PIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161823-B2 Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof NATIONAL GUARD HEALTH AFFAIRS (SA) 2021-11-02 — — US disclosed
US-20200290975-A1 ANTICANCER 1,3-DIOXANE-4,6-DIONE DERIVATIVES AND METHOD OF COMBINATORIAL SYNTHESIS THEREOF NATIONAL GUARD HEALTH AFFAIRS (SA) 2020-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161823-B2 Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof PDK1, PDHA1, PDHA2 CISD1 2405/4885PIK3CD 2741/4885CSNK2A2 2801/4885
US-20200290975-A1 ANTICANCER 1,3-DIOXANE-4,6-DIONE DERIVATIVES AND METHOD OF COMBINATORIAL SYNTHESIS THEREOF PDK1, PDHA1, PDHA2 CISD1 2405/4885PIK3CD 2741/4885CSNK2A2 2801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback